Literature DB >> 16621996

IL-4 induces in vivo production of IFN-gamma by NK and NKT cells.

Suzanne C Morris1, Tatyana Orekhova, Michelle J Meadows, Stephanie M Heidorn, Junqi Yang, Fred D Finkelman.   

Abstract

Although IL-4 and IFN-gamma often have opposite effects and suppress each other's production by T cells, IL-4 can stimulate IFN-gamma production. To characterize this, we injected mice with IL-4 and quantified IFN-gamma production with the in vivo cytokine capture assay. IL-4 induced Stat6-dependent IFN-gamma production by NK and, to a lesser extent, NKT cells, but not conventional T cells, in 2-4 h. Increased IFN-gamma production persisted at a constant rate for >24 h, but eventually declined, even with continuing IL-4 stimulation. This eventual decline in IFN-gamma production was accompanied by a decrease in NK and T cell numbers. Consistent with a dominant role for NK cells in IL-4-stimulated IFN-gamma secretion, IL-4 induction of IFN-gamma was B and T cell-independent; suppressed by an anti-IL-2Rbeta mAb that eliminates most NK and NKT cells; reduced in Stat4-deficient mice, which have decreased numbers of NK cells; and absent in Rag2/gamma(c)-double-deficient mice, which lack T, B, and NK cells. IL-4-induced IFN-gamma production was not affected by neutralizing IL-12p40 and was increased by neutralizing IL-2. IL-13, which signals through the type 2 IL-4R and mimics many IL-4 effects, failed to stimulate IFN-gamma production and, in most experiments, suppressed basal IFN-gamma production. Thus, IL-4, acting through the type 1 IL-4R, induces Stat6-dependent IFN-gamma secretion by NK and NKT cells. This explains how IL-4 can contribute to Th1 cytokine-associated immune effector functions and suggests how IL-13 can have stronger proallergic effects than IL-4.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621996     DOI: 10.4049/jimmunol.176.9.5299

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Serum profile of pro- and anti-inflammatory cytokines in rats following implantation of low-temperature plasma-modified titanium plates.

Authors:  Uwe Walschus; Andreas Hoene; Maciej Patrzyk; Birgit Finke; Martin Polak; Silke Lucke; Barbara Nebe; Karsten Schroeder; Andreas Podbielski; Lutz Wilhelm; Michael Schlosser
Journal:  J Mater Sci Mater Med       Date:  2012-03-09       Impact factor: 3.896

2.  Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells.

Authors:  Brian Becknell; Tiffany L Hughes; Aharon G Freud; Bradley W Blaser; Jianhua Yu; Rossana Trotta; Hsiaoyin C Mao; Marie L Caligiuri de Jesús; Mohamad Alghothani; Don M Benson; Amy Lehman; David Jarjoura; Danilo Perrotti; Michael D Bates; Michael A Caligiuri
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

3.  IL-7Rα Expression Regulates Murine Dendritic Cell Sensitivity to Thymic Stromal Lymphopoietin.

Authors:  Laura Kummola; Zsuzsanna Ortutay; Xi Chen; Stephane Caucheteux; Sanna Hämäläinen; Saara Aittomäki; Ryoji Yagi; Jinfang Zhu; Marko Pesu; William E Paul; Ilkka S Junttila
Journal:  J Immunol       Date:  2017-04-12       Impact factor: 5.422

Review 4.  Importance of cytokines in murine allergic airway disease and human asthma.

Authors:  Fred D Finkelman; Simon P Hogan; Gurjit K Khurana Hershey; Marc E Rothenberg; Marsha Wills-Karp
Journal:  J Immunol       Date:  2010-02-15       Impact factor: 5.422

5.  In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

Authors:  Charles S Via; Kateryna Soloviova; Maksym Puliaiev; Roman Puliav; Irina Puliaeva; Suzanne C Morris; Fred D Finkelman
Journal:  Clin Immunol       Date:  2017-03-27       Impact factor: 3.969

6.  B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus.

Authors:  Arpita Choudhury; Philip L Cohen; Robert A Eisenberg
Journal:  Clin Immunol       Date:  2010-04-08       Impact factor: 3.969

7.  IL-33 promotes type 1 cytokine expression via p38 MAPK in human NK cells.

Authors:  David E Ochayon; Ayad Ali; Pablo C Alarcon; Durga Krishnamurthy; Leah C Kottyan; Michael T Borchers; Stephen N Waggoner
Journal:  J Leukoc Biol       Date:  2020-02-04       Impact factor: 4.962

8.  Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation.

Authors:  Joshua D Milner; Tatyana Orekov; Jerrold M Ward; Lily Cheng; Fernando Torres-Velez; Ilkka Junttila; Guangping Sun; Mark Buller; Suzanne C Morris; Fred D Finkelman; William E Paul
Journal:  Blood       Date:  2010-06-22       Impact factor: 22.113

9.  Signaling through the interleukin-4 and interleukin-13 receptor complexes regulates cholangiocyte TMEM16A expression and biliary secretion.

Authors:  Amal K Dutta; Kristy Boggs; Al-Karim Khimji; Yonas Getachew; Youxue Wang; Charles Kresge; Don C Rockey; Andrew P Feranchak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-24       Impact factor: 4.052

10.  Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-gamma and IL-4.

Authors:  Akira Iizuka; Yoshinori Ikarashi; Mitsuzi Yoshida; Yuji Heike; Kazuyoshi Takeda; Gary Quinn; Hiro Wakasugi; Masanobu Kitagawa; Yoichi Takaue
Journal:  Immunology       Date:  2007-11-14       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.